This low rate of toxicity, especially of xerostomia, may be related to the lower administered activity of 225Ac (mean: 44 kBq/kg BW) in comparison to other studies applying [225Ac]Ac-PSMA-617 as monotherapy 19,20,22. This evidence concerns the gene FOLH1 and xerostomia.